Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Remarkable enhancement of productivity for drugs through new real-time quality control

06.09.2005


The Technical Research Centre of Finland, VTT has developed a new method, which increases product development cycle. This process will also enhance the competitiveness of drug development and reduce costs. VTT is working in collaboration with GlaxoSmithKline, GSK, one of the leading international pharmaceutical companies, to enhance quality control for drugs by using Process Analytical Technologies (PAT). The goal of the PAT is to develop drug process’ production analysis into real-time quality control and to decrease significantly production costs.



VTT’s optical measurement methods, in drug production, will help pharmaceutical companies increase the quality and safety of their products. Manufacturing cost of drugs play an important role in the cost of pharmaceutical products, as 40% of the price is coming from production.

One of the major problems in developing drug manufacturing processes is the lack of fast and reliable measurement techniques. At the moment, the quality measurement technique consists mainly of slow laboratory analyses, which do not enable real-time quality control. The effective manufacturing of a drug takes only one to two days whereas in practice the whole manufacturing process may take as long as 30-60 days.


VTT has one of the world’s largest groups of specialists, totally 45 man-years annual volume, developing on new process measurement equipment. At the moment, VTT has developed state-of-art optical instrumentation mainly for other process industries such as pulp&paper and metal. In this project the challenge is to transfer and utilize this Finnish process measurement knowledge to the pharmaceutical processes. VTT will collaborate with GSK to improve GSK drug manufacturing processes by using the high-tech PAT technologies.

VTT and GSK assignment is significant for VTT as the two -year project is worth up to 1.5 million Euro. The main target of this project is to create and develop new innovative measurement systems and business opportunities to Finnish measurement and sensor companies. Measurement systems will be tested in several production lines including GSK plants in UK, Italy, Spain and Canada.

Finnish industry has been to the forefront in developing strong industrial process understanding, strongly supported by the collaborative R&D work undertaken by renowned institutes such as VTT. The various R&D programs have been coordinated, advised and supported by Tekes, the Finnish national technology agency, whose strategy is to develop new international links for Finnish technology abroad.

Irene Hernberg | alfa
Further information:
http://www.vtt.fi

More articles from Health and Medicine:

nachricht Spanish scientists create a 3-D bioprinter to print human skin
24.01.2017 | Carlos III University of Madrid

nachricht Tracking movement of immune cells identifies key first steps in inflammatory arthritis
23.01.2017 | Massachusetts General Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists spin artificial silk from whey protein

X-ray study throws light on key process for production

A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Breaking the optical bandwidth record of stable pulsed lasers

24.01.2017 | Physics and Astronomy

Choreographing the microRNA-target dance

24.01.2017 | Life Sciences

Spanish scientists create a 3-D bioprinter to print human skin

24.01.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>